معرفی
Dr. James Carson is a Professor in the Department of Kinesiology & Sports Management at Texas A&M University and the Executive Director of the Huffines Institute for Sports Medicine & Human Performance. He holds the Debbie & Mike Hilliard ’73 Endowed Chair. With expertise in exercise physiology and molecular biology, Dr. Carson’s research focuses on skeletal muscle metabolism, cancer cachexia, and chronic inflammation. He has over 150 publications and 12,000 citations, with 41 papers exceeding 100 citations each.
Education: B.S. in Business Administration and Ph.D. in Education (Exercise Physiology) from The Ohio State University. Post-doctoral training at Baylor College of Medicine and the University of Texas Health Science Center-Houston. Former roles include Associate Dean for Research at the University of Tennessee Health Science Center and Department Chair at the University of South Carolina.
Research Interests: Molecular mechanisms of muscle wasting in cancer, mitochondrial dysfunction, and exercise interventions to counteract metabolic disorders. His work bridges basic science and clinical applications, emphasizing translational outcomes.
Publications: Over 150 refereed articles in journals such as Journal of Applied Physiology and Cancer Research, with a focus on cancer cachexia, muscle regeneration, and exercise physiology. Recent studies explore mitochondrial dynamics and immune cell interactions in cancer progression.
Awards: Not explicitly listed, but his extensive federal funding (NIH, VA) and editorial roles (two journals) highlight recognition in his field.
Leadership & Mentorship: Extensive experience mentoring students and junior faculty. Served in administrative roles overseeing research programs, faculty recruitment, and academic growth. Active on grant review panels for NIH and VA.
Labs & Teams: Leads the Huffines Institute and collaborates with interdisciplinary teams in regenerative medicine and sports performance. His research integrates molecular biology, exercise science, and clinical oncology.
